Sarah C. Garrett-Thomson

1.5k total citations · 1 hit paper
10 papers, 714 citations indexed

About

Sarah C. Garrett-Thomson is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Sarah C. Garrett-Thomson has authored 10 papers receiving a total of 714 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Sarah C. Garrett-Thomson's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Sarah C. Garrett-Thomson is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (4 papers) and Immune Cell Function and Interaction (4 papers). Sarah C. Garrett-Thomson collaborates with scholars based in United States, Mexico and China. Sarah C. Garrett-Thomson's co-authors include Alan J. Korman, Nils Lönberg, Steven C. Almo, U.A. Ramagopal, Weifeng Liu, J.B. Bonanno, Qingrong Yan, M. S. Srinivasan, Susan Wong and Vangipuram S. Rangan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Sarah C. Garrett-Thomson

10 papers receiving 708 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The foundations of immune checkpoint blockade and the ipilimumab approval decennial

2021 374 citations Alan J. Korman, Sarah C. Garrett-Thomson et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah C. Garrett-Thomson United States	8	497	387	188	97	71	10	714
Jonathan Chabon United States	5	505 1.0×	466 1.2×	259 1.4×	67 0.7×	74 1.0×	7	819
Kyle R. Cron United States	4	299 0.6×	584 1.5×	219 1.2×	85 0.9×	41 0.6×	10	794
Greg Motz United States	5	590 1.2×	653 1.7×	232 1.2×	109 1.1×	92 1.3×	10	947
Xuexiang Du United States	10	586 1.2×	504 1.3×	204 1.1×	61 0.6×	59 0.8×	21	856
Jiemiao Hu United States	15	327 0.7×	379 1.0×	172 0.9×	62 0.6×	80 1.1×	32	657
Steven K. Grossenbacher United States	15	514 1.0×	583 1.5×	175 0.9×	43 0.4×	93 1.3×	21	855
Huiping Gao China	12	616 1.2×	392 1.0×	248 1.3×	142 1.5×	39 0.5×	22	889
Xuekai Zhu China	12	489 1.0×	247 0.6×	262 1.4×	174 1.8×	59 0.8×	23	723
Sugandha Saxena United States	14	438 0.9×	407 1.1×	228 1.2×	64 0.7×	92 1.3×	28	832
Diana V. Yuzhakova Russia	10	278 0.6×	288 0.7×	129 0.7×	103 1.1×	139 2.0×	28	588

Countries citing papers authored by Sarah C. Garrett-Thomson

Since Specialization

Citations

This map shows the geographic impact of Sarah C. Garrett-Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah C. Garrett-Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah C. Garrett-Thomson more than expected).

Fields of papers citing papers by Sarah C. Garrett-Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah C. Garrett-Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah C. Garrett-Thomson. The network helps show where Sarah C. Garrett-Thomson may publish in the future.

Co-authorship network of co-authors of Sarah C. Garrett-Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah C. Garrett-Thomson. A scholar is included among the top collaborators of Sarah C. Garrett-Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah C. Garrett-Thomson. Sarah C. Garrett-Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Morano, Nicholas C., Ryan Schreiner, Natalia G. Herrera, et al.. (2022). Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor. Journal of Clinical Investigation. 132(22). 4 indexed citations

2.

Korman, Alan J., Sarah C. Garrett-Thomson, & Nils Lönberg. (2022). Author Correction: The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nature Reviews Drug Discovery. 21(2). 163–163. 9 indexed citations

3.

Liu, Weifeng, Sarah C. Garrett-Thomson, Goo‐Young Seo, et al.. (2021). HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160. The Journal of Experimental Medicine. 218(12). 20 indexed citations

4.

Garrett-Thomson, Sarah C., et al.. (2021). Allosteric regulation of binding specificity of HVEM for CD160 and BTLA ligands upon G89F mutation. SHILAP Revista de lepidopterología. 3. 337–345. 1 indexed citations

5.

Korman, Alan J., Sarah C. Garrett-Thomson, & Nils Lönberg. (2021). The foundations of immune checkpoint blockade and the ipilimumab approval decennial. Nature Reviews Drug Discovery. 21(7). 509–528. 374 indexed citations breakdown →

6.

Garrett-Thomson, Sarah C., Aldo Massimi, E.V. Fedorov, et al.. (2020). Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune complex. PLoS ONE. 15(6). e0233578–e0233578. 24 indexed citations

7.

Garrett-Thomson, Sarah C., et al.. (2020). Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160. Structure. 28(11). 1197–1205.e2. 13 indexed citations

8.

Smith, Eric L., Mette Stæhr, Reed Masakayan, et al.. (2018). Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector. Molecular Therapy. 26(6). 1447–1456. 76 indexed citations

9.

Ramagopal, U.A., Weifeng Liu, Sarah C. Garrett-Thomson, et al.. (2017). Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab. Proceedings of the National Academy of Sciences. 114(21). E4223–E4232. 133 indexed citations

10.

Jeon, Hyungjun, Vladimir Vigdorovich, Sarah C. Garrett-Thomson, et al.. (2014). Structure and Cancer Immunotherapy of the B7 Family Member B7x. Cell Reports. 9(3). 1089–1098. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact